Granules India Limited (IN:GRANULES)
:GRANULES
GRANULES Stock Chart & Stats
₹615.10
₹1.80(0.30%)
At close: 4:00 PM EST
₹615.10
₹1.80(0.30%)
Day’s Range― - ―
52-Week Range₹430.60 - ₹654.85
Previous CloseN/A
Volume528.44K
Average Volume (3M)56.05K
Market Cap
₹156.79B
Enterprise Value₹168.69B
Total Cash (Recent Filing)₹6.26B
Total Debt (Recent Filing)₹18.07B
Price to Earnings (P/E)24.2
Beta1.06
Next Earnings
May 20, 2026EPS Estimate
6.05Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)6.20
Shares Outstanding247,796,920
10 Day Avg. Volume60,875
30 Day Avg. Volume56,048
Financial Highlights & Ratios
PEG Ratio0.99
Price to Book (P/B)3.15
Price to Sales (P/S)2.61
P/FCF Ratio60.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹682.00Price Target Upside10.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)31.68
Revenue Forecast (FY)₹61.00B
Bulls Say, Bears Say
Bulls Say
Cash GenerationGranules' robust operating cash flow and materially improved free cash flow indicate durable internal financing ability. Strong cash conversion supports capex for capacity, servicing of existing debt, and funding strategic R&D or FDF scaling without relying solely on external capital.
Profitability & MarginsConsistently high gross and solid net margins reflect manufacturing scale, cost control and operational efficiency. Sustainable margins provide a buffer against generic pricing cycles and support reinvestment and shareholder returns over the medium term.
Integrated Generics Value ChainVertical presence across APIs, PFIs and finished dosages gives Granules control over inputs, better margin capture and diversification across B2B and FDF channels. Access to regulated markets increases revenue durability and makes customer relationships more sticky over time.
Bears Say
LeverageModerately high leverage constrains financial flexibility and raises sensitivity to interest rates and cash flow shocks. Ongoing debt servicing needs can limit capital allocation to growth projects or acquisitions and heighten risk if margins or cash flows weaken.
Revenue VolatilityFluctuating revenue and a recent slight decline point to exposure to product mix shifts, regulatory timing and tender cycles. Persistent volatility complicates forecasting and long-term capacity planning, potentially pressuring margins and return on invested capital.
Commodity Pricing ExposureHeavy exposure to off-patent APIs and commoditized intermediates subjects recurring revenues to pricing competition and margin erosion. Without faster migration to higher-value FDF or differentiated products, structural pricing pressure could cap long-term margin expansion.
Granules India Limited News
GRANULES FAQ
What was Granules India Limited’s price range in the past 12 months?
Granules India Limited lowest stock price was ₹430.60 and its highest was ₹654.85 in the past 12 months.
What is Granules India Limited’s market cap?
Granules India Limited’s market cap is ₹156.79B.
When is Granules India Limited’s upcoming earnings report date?
Granules India Limited’s upcoming earnings report date is May 20, 2026 which is in 35 days.
How were Granules India Limited’s earnings last quarter?
Granules India Limited released its earnings results on Jan 23, 2026. The company reported ₹6.2 earnings per share for the quarter, beating the consensus estimate of ₹5.85 by ₹0.35.
Is Granules India Limited overvalued?
According to Wall Street analysts Granules India Limited’s price is currently Undervalued.
Does Granules India Limited pay dividends?
Granules India Limited pays a Annually dividend of ₹1.5 which represents an annual dividend yield of 0.24%. See more information on Granules India Limited dividends here
What is Granules India Limited’s EPS estimate?
Granules India Limited’s EPS estimate is 6.05.
How many shares outstanding does Granules India Limited have?
Granules India Limited has 247,796,920 shares outstanding.
What happened to Granules India Limited’s price movement after its last earnings report?
Granules India Limited reported an EPS of ₹6.2 in its last earnings report, beating expectations of ₹5.85. Following the earnings report the stock price went down -1.094%.
Which hedge fund is a major shareholder of Granules India Limited?
Currently, no hedge funds are holding shares in IN:GRANULES
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
GRANULES Stock 12 Month Forecast
Average Price Target
₹682.00
▲(10.88% Upside)
Technical Analysis
Alembic Pharmaceuticals Limited
―
Aurobindo Pharma Ltd
―
Cipla Ltd
―
Glenmark Pharmaceuticals Limited
―
Sanofi India Limited
―